Your doctor may also prescribe Mounjaro off-label for weight management. (Off-label use of a drug is when your doctor prescribes a medication for a different use than what it was approved for.) ...

In the head-to-head clinical trial with main GLP-1 agonist competitor Ozempic, Mounjaro was shown to be better at lowering HbA1c and reducing body weight. SURPASS-2 was an open label, 40-week ...

Currently, Mounjaro has not been approved by the FDA for weight loss, though some doctors prescribe it as an off-label weight loss medication for certain patients. Because of the success of ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

Mounjaro is approved by the Food and Drug Administration to improve blood sugar control in adults with type 2 diabetes. It's also frequently prescribed for weight loss off-label. Unlike many of ...

Like most drugs, Mounjaro can cause side effects. Hair loss was not a reported side effect of Mounjaro, but it was reported with other GLP-1 agonists. Mounjaro can cause side effects, such as ...

“It” being sex, of course. But shortly after beginning a regimen of compounded tirzepatide, the generic version of anti-obesity jabs like Mounjaro, in August, her hankering for hanky-panky vanishe ...

Doctors can prescribe Mounjaro off-label for weight loss, but the drug does not have FDA approval for this use. Tirzepatide is FDA-approved for weight loss as the brand-name drug Zepbound.

Recent medical evaluations have raised serious concerns about the safety of widely prescribed GLP-1 medications, such as Ozempic and Mounjaro, after emerging reports of vision complications.